Home >> ALL ISSUES >> 2020 Issues >> Put It on the Board

Put It on the Board

image_pdfCreate PDF

Qiagen and DiaSorin began to collaborate in 2017 to develop new tests for the Liaison family of analyzers based on Qiagen assay technologies. Qiagen is also partnering with two leaders in liquid handling solutions to provide options for automated preanalytical processing for customers who implement the single-tube collection process for QFT-Plus. These collaborations enable customers to use the Hamilton Robotics Microlab Star automated liquid handling workstation or the Tecan Fluent Laboratory Automation workstation to automate the manual step of aliquoting samples from a single collection device (such as a standard lithium heparin blood collection tube) into Quanti­Feron-TB Gold Plus tubes for analysis.

CE-IVD launch of Cobas Zika test

Roche announced in December the CE-IVD launch of its Cobas Zika test for use on the Cobas 6800/8800 systems.

The test is a qualitative in vitro nucleic acid screening test for the direct detection of Zika virus RNA in plasma specimens from donors of whole blood and blood components and other living donors.

New DPA president

Rivers

Michael Rivers, VP of Roche Digital Pathology, has been named president of the Digital Pathology Association, effective Jan. 1. He succeeds Marilyn Bui, MD, PhD, senior member in the Department of Anatomic Pathology and scientific director of analytic microscopy core at Mof­fitt Cancer Center.

Rivers and the DPA board are focused on growing the organization outside the U.S. “The goal of the DPA is to become the global driving force for digital pathology,” Rivers said in a statement. “I would like us to become the go-to organization for medical professionals that are interested in the adoption of digital pathology.”

CAP TODAY
X